The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507
Official Title: A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507 in Subjects With Cancer
Study ID: NCT02597465
Brief Summary: An open label study to determine the efficacy and safety of SPARC1507
Detailed Description: Subjects with advanced Biliary tract carcinoma meeting the eligibility criteria will be randomized in this study.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
SPARC study site, Aurora, Colorado, United States